164 related articles for article (PubMed ID: 29130797)
1. Dose-finding study of carbamylated monomeric allergoid tablets in grass-allergic rhinoconjunctivitis patients.
Mösges R; Rohdenburg C; Eichel A; Zadoyan G; Kasche EM; Shah-Hosseini K; Lehmacher W; Schmalz P; Compalati E
Immunotherapy; 2017 Nov; 9(15):1225-1238. PubMed ID: 29130797
[TBL] [Abstract][Full Text] [Related]
2. Safety Review of 5-Grass Pollen Tablet from Pooled Data of Clinical Trials.
Casale TB; Cox LS; Wahn U; Golden DBK; Bons B; Didier A
J Allergy Clin Immunol Pract; 2017; 5(6):1717-1727.e1. PubMed ID: 28734858
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy With the SQ Tree SLIT-tablet in Adults and Adolescents With Allergic Rhinoconjunctivitis.
Mäkelä MJ; Gyllfors P; Valovirta E; Steffensen MA; Grønager PM; Savolainen J; Winther L
Clin Ther; 2018 Apr; 40(4):574-586.e4. PubMed ID: 29551533
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis.
Malling HJ; Montagut A; Melac M; Patriarca G; Panzner P; Seberova E; Didier A
Clin Exp Allergy; 2009 Mar; 39(3):387-93. PubMed ID: 19134019
[TBL] [Abstract][Full Text] [Related]
6. Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais® tablets.
Mösges R; Ritter B; Kayoko G; Allekotte S
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):3-10. PubMed ID: 20976414
[TBL] [Abstract][Full Text] [Related]
7. A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients.
Hüser C; Dieterich P; Singh J; Shah-Hosseini K; Allekotte S; Lehmacher W; Compalati E; Mösges R
Allergy; 2017 Jan; 72(1):77-84. PubMed ID: 27068870
[TBL] [Abstract][Full Text] [Related]
8. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.
Ellis AK; Frankish CW; O'Hehir RE; Armstrong K; Steacy L; Larché M; Hafner RP
J Allergy Clin Immunol; 2017 Aug; 140(2):486-496. PubMed ID: 28236469
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
10. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.
Spertini F; DellaCorte G; Kettner A; de Blay F; Jacobsen L; Jutel M; Worm M; Charlon V; Reymond C
J Allergy Clin Immunol; 2016 Jul; 138(1):162-8. PubMed ID: 27373329
[TBL] [Abstract][Full Text] [Related]
12. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis.
di Coste A; Occasi F; De Castro G; Zicari AM; Galandrini R; Giuffrida A; Indinnimeo L; Duse M
Allergol Immunopathol (Madr); 2017; 45(5):452-456. PubMed ID: 28410874
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review.
Didier A; Bons B
Expert Opin Drug Saf; 2015 May; 14(5):777-88. PubMed ID: 25732009
[TBL] [Abstract][Full Text] [Related]
14. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
Devillier P; Wahn U; Zielen S; Heinrich J
Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
[TBL] [Abstract][Full Text] [Related]
15. Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?
Nelson HS; Durham SR
J Allergy Clin Immunol Pract; 2017; 5(1):52-57. PubMed ID: 28065341
[No Abstract] [Full Text] [Related]
16. Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: A 3-year randomized placebo-controlled trial.
Skaarup SH; Schmid JM; Skjold T; Graumann O; Hoffmann HJ
J Allergy Clin Immunol; 2021 Mar; 147(3):1011-1019. PubMed ID: 32679209
[TBL] [Abstract][Full Text] [Related]
17. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
Pfaar O; Richter HG; Klimek L; Sieber J; Hadler M; Karagiannis E
Biomed Res Int; 2015; 2015():584291. PubMed ID: 26351635
[TBL] [Abstract][Full Text] [Related]
18. Sublingual Tablet Immunotherapy Improves Quality of Life in Adults With Allergic Rhinoconjunctivitis.
Blaiss MS; Durham SR; Bernstein D; Stranzl T; Lindholm M; Nolte H; Andersen KF; Roberts G
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1520-1529.e5. PubMed ID: 38307205
[TBL] [Abstract][Full Text] [Related]
19. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
[TBL] [Abstract][Full Text] [Related]
20. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment.
Horak F; Jaeger S; Worm M; Melac M; Didier A
Clin Exp Allergy; 2009 Mar; 39(3):394-400. PubMed ID: 19134018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
